<unk>  refers to a chemoimmunotherapy regimen consisting of rituximab, ifosfamide, carboplatin and etoposide used to treat indolent and aggressive forms of non-Hodgkin's lymphoma; also used to treat relapsed and refractory non-Hodgkin's lymphoma.
ICE-R regimen
TIP regimen
MINE-R regimen
FMC-R regimen
DHAX-R regimen
RCD regimen
CEOP-R regimen
EOX regimen